Management of cerebral vasospasm

Area of Science:

• Neurology
• Neurosurgery
• Radiology

Background:

• Cerebral vasospasm is a critical complication following aneurysmal subarachnoid hemorrhage (SAH).
• It represents a significant, treatable cause of delayed neurological deterioration, morbidity, and mortality post-SAH.
• The presence and severity of vasospasm correlate with early indicators like subarachnoid clot characteristics.

Purpose of the Study:

• To review the pathophysiology, diagnosis, and management of cerebral vasospasm after SAH.
• To highlight the challenges and limitations in current treatment strategies.
• To emphasize the importance of early detection and intervention.

Main Methods:

• Review of literature on cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
• Analysis of diagnostic modalities including catheter angiography, CT angiography, and transcranial Doppler ultrasound.
• Evaluation of treatment strategies encompassing hemodynamic optimization, nimodipine administration, and angioplasty.

Main Results:

• Vasospasm typically occurs 4-14 days post-SAH.
• Diagnosis relies on angiography, with other methods offering less accuracy.
• Predictive factors include clot volume, location, persistence, and density.

Conclusions:

• Cerebral vasospasm is a major, treatable cause of poor outcomes after SAH.
• Current treatments are often costly, time-consuming, risky, and largely ineffective.
• Further research and improved therapeutic approaches are needed to effectively manage this condition.